Skip to content

EXOZ EXOZ Financing Cash Flow

Financing Cash Flow at other companies

Gevo logo
GevoGEVO
-$7.77M-107%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$19K+90.8%
NAG
Niagen Bioscience, Inc. Common StockNAGE
-$2.29M-174%
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
-$1.58M-116%
Opko Health logo
Opko HealthOPK
-$5.16M-28.2%
Upexi logo
UpexiUPXI
$8.55M

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's financing cash flow?
EXOZ (EXOZ) reported financing cash flow of -$12.74K in Q1 2026.
How has EXOZ's financing cash flow changed year-over-year?
EXOZ's financing cash flow increased by 70.6% year-over-year, from -$43.25K to -$12.74K.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.